Manujendra N. Saha - Publications

Endogenous H2S production deficiencies lead to impaired renal erythropoietin production.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: November 27, 2018

Reconstitution of T-Cell Subsets Following Thymoglobulin-Induced Depletion in High Immunologic Risk and Donation After Cardiac Death Renal Transplant Recipients.

Journal: Transplantation proceedings

Published: October 09, 2018

CORM-401 Reduces Ischemia Reperfusion Injury in an Ex Vivo Renal Porcine Model of the Donation After Circulatory Death.

Journal: Transplantation

Published: April 21, 2018

A novel approach to off-clamp partial nephrectomy demonstrates significant improvements in renal injury in an experimental porcine model.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: February 01, 2018

A Hibernation-Like State for Transplantable Organs: Is Hydrogen Sulfide Therapy the Future of Organ Preservation?

Journal: Antioxidants & redox signaling

Published: July 28, 2017

Hydrogen Sulfide Protects Renal Grafts Against Prolonged Cold Ischemia-Reperfusion Injury via Specific Mitochondrial Actions.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: July 31, 2016

Hydrogen Sulfide Induced Erythropoietin Synthesis is Regulated by HIF Proteins.

Journal: The Journal of urology

Published: January 12, 2016

MiRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-Myc.

Journal: Oncotarget

Published: September 03, 2015

miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 04, 2014

Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma.

Journal: Leukemia

Published: April 30, 2014

Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents.

Journal: British journal of cancer

Published: February 25, 2014

PRIMA-1Met/APR-246 displays high antitumor activity in multiple myeloma by induction of p73 and Noxa.

Journal: Molecular cancer therapeutics

Published: September 14, 2013